NASDAQ:AMLX | Total Assets | Amylyx Pharmaceuticals, Inc.

Complete source-backed total assets history.

Available history
2021-12-31 to 2026-06-30
Data captured

Historical Total Assets

DateTotal assetsCurrent assetsCash and equivalentsCurrent securitiesReceivablesInventoryProperty, plant and equipmentOther noncurrent assets
2026-06-30$264.56M$256.34M$49.33M$201.43M$199,000.00
2026-03-31$293.6M$285.02M$229.14M$50.63M$212,000.00$2.5M
2025-12-31$332.65M$323.67M$226.65M$90.33M$88,000.00$310,000.00$2.5M
2025-09-30$362.74M$353.38M$225.18M$118.81M$132,000.00$399,000.00$2.5M
2025-06-30$194.6M$186.89M$58.09M$122.74M$103,000.00$445,000.00
2025-03-31$219.68M$216.14M$59.76M$144.3M$300,000.00$816,000.00$11,000.00
2024-12-31$193.63M$189.43M$77.39M$99.11M$447,000.00$961,000.00$24,000.00
2024-09-30$250.71M$245.26M$71.84M$162.56M$1.73M$1.25M$482,000.00
2024-06-30$332.16M$326.72M$75M$234.81M$4.09M$1.47M$479,000.00
2024-03-31$417.46M$410.53M$170.55M$202.74M$20.35M$2.46M$493,000.00
2023-12-31$517.45M$464.67M$170.2M$201.16M$40.05M$38.32M$2.69M$701,000.00
2023-09-30$466.58M$434.11M$135.26M$219.79M$29.35M$32.37M$2.76M$476,000.00
2023-06-30$453.59M$427.39M$247.76M$109.52M$33.47M$24.86M$2.64M$466,000.00
2023-03-31$407.96M$389.05M$114.56M$231.11M$17.56M$13.08M$2.56M$466,000.00
2022-12-31$391.45M$382.13M$62.53M$284.42M$15.31M$9.77M$2.61M$466,000.00
2022-09-30$181.44M$172.2M$107.73M$54.86M$137,000.00$563,000.00$2.12M$456,000.00
2022-06-30$225.24M$216.14M$67.44M$139.24M$1.86M$456,000.00
2022-03-31$274.44M$265.49M$110.4M$144.8M$1.29M$456,000.00
2021-12-31$105.61M$104.95M$50.19M$45.93M$474,000.00